Charles Schwab’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $40.5K | Hold |
|
|||||
|
2024
Q2 | $37.5K | Hold |
|
|||||
|
2024
Q1 | $58.1K | Hold |
|
|||||
|
2023
Q4 | $51.8K | Hold |
|
|||||
|
2023
Q3 | $37.5K | Hold |
|
|||||
|
2023
Q2 | $30.8K | Sell |
|
|||||
|
2023
Q1 | $167K | Buy |
|
|||||
|
2022
Q4 | $214K | Sell |
|
|||||
|
2022
Q3 | $2.61M | Sell |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $1.81M | Buy |
|
|||||
|
2021
Q4 | $1.02M | Buy |
|
|||||
|
2021
Q3 | $1.08M | Sell |
|
|||||
|
2021
Q2 | $3.17M | Buy |
|
|||||
|
2021
Q1 | $3.33M | Buy |
|
|||||
|
2020
Q4 | $2.98M | Buy |
|
|||||
|
2020
Q3 | $3.37M | Sell |
|
|||||
|
2020
Q2 | $4.03M | Buy |
|
|||||
|
2020
Q1 | $1.82M | Buy |
|
|||||
|
2019
Q4 | $1.92M | Buy |
|